![Don Cilla](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 900 $ al 31/05/2026
Don Cilla is currently President, Chief Executive Officer & Director at Appili Therapeutics, Inc. since 2022, with employment at the firm starting in 2019.
Education includes a doctorate from the University of Michigan and an MBA from the University of Phoenix.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2025 | 75.000 ( 0,06 % ) | 900 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| APPILI THERAPEUTICS INC. | Director Ejecutivo | 01/11/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Phoenix
 University of Phoenix Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Appili Therapeutics, Inc.
 Appili Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for infectious disease | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
